Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4636427014 | Product containing precisely nitazoxanide 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4636428016 | Nitazoxanide 200 mg tablet for oral suspension | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely nitazoxanide 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) | est un(e) (attribut) | Product containing only nitazoxanide in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely nitazoxanide 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) | a une forme pharmaceutique (attribut) | Tablet for oral suspension | true | Inferred relationship | Some | ||
| Product containing precisely nitazoxanide 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely nitazoxanide 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Plays role | Antiprotozoal therapeutic role | true | Inferred relationship | Some | ||
| Product containing precisely nitazoxanide 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has precise active ingredient | Nitazoxanide | true | Inferred relationship | Some | 1 | |
| Product containing precisely nitazoxanide 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has basis of strength substance (attribute) | Nitazoxanide | true | Inferred relationship | Some | 1 | |
| Product containing precisely nitazoxanide 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
| Product containing precisely nitazoxanide 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Canada English language reference set (foundation metadata concept)
FHIR